<VariationArchive VariationID="473720" VariationName="NM_006231.4(POLE):c.5265del (p.Ile1756fs)" VariationType="Deletion" Accession="VCV000473720" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-12-26" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="461811" VariationID="473720">
      <GeneList>
        <Gene Symbol="POLE" FullName="DNA polymerase epsilon, catalytic subunit" GeneID="5426" HGNC_ID="HGNC:9177" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="132623762" stop="132687342" display_start="132623762" display_stop="132687342" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="133200347" stop="133263944" display_start="133200347" display_stop="133263944" Strand="-" />
          </Location>
          <OMIM>174762</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POLE">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=POLE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006231.4(POLE):c.5265del (p.Ile1756fs)</Name>
      <CanonicalSPDI>NC_000012.12:132641759:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="132641760" stop="132641760" display_start="132641760" display_stop="132641760" variantLength="1" positionVCF="132641759" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="133218346" stop="133218346" display_start="133218346" display_stop="133218346" variantLength="1" positionVCF="133218345" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I1756fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.133218349del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.133218349del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.132641763del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.132641763del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033840.1" sequenceAccession="NG_033840" sequenceVersion="1" change="g.50765del">
            <Expression>NG_033840.1:g.50765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006231.4" sequenceAccession="NM_006231" sequenceVersion="4" change="c.5265del" MANESelect="true">
            <Expression>NM_006231.4:c.5265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006222.2" sequenceAccession="NP_006222" sequenceVersion="2" change="p.Ile1756fs">
            <Expression>NP_006222.2:p.Ile1756fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_789" sequenceAccession="LRG_789">
            <Expression>LRG_789:g.50765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_789t1" sequenceAccession="LRG_789t1">
            <Expression>LRG_789t1:c.5265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_789p1" sequenceAccession="LRG_789p1" change="p.Ile1756fs">
            <Expression>LRG_789p1:p.Ile1756fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006231.3" sequenceAccession="NM_006231" sequenceVersion="3" change="c.5265delG">
            <Expression>NM_006231.3:c.5265delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1555222342" DB="dbSNP" />
        <XRef ID="CA658658210" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="174762.0004" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006231.4(POLE):c.5265del (p.Ile1756fs) AND Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency" Accession="RCV000757961" Version="2">
        <ClassifiedConditionList TraitSetID="46436">
          <ClassifiedCondition DB="MedGen" ID="C5193036">Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-02-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006231.4(POLE):c.5265del (p.Ile1756fs) AND not provided" Accession="RCV003539945" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006231.4(POLE):c.5265del (p.Ile1756fs) AND POLE-related disorder" Accession="RCV004543220" Version="1">
        <ClassifiedConditionList TraitSetID="80472">
          <ClassifiedCondition>POLE-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-12" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-12-26" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23230001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25948378</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30503519</ID>
        </Citation>
        <DescriptionHistory Dated="2024-03-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-03-04">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-03-04">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="46436" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="41419" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IMAGEI SYNDROME</ElementValue>
                <XRef Type="MIM" ID="618336" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency</ElementValue>
                <XRef ID="MONDO:0032684" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IMAGEI</ElementValue>
                <XRef Type="MIM" ID="618336" DB="OMIM" />
              </Symbol>
              <XRef ID="C5193036" DB="MedGen" />
              <XRef ID="MONDO:0032684" DB="MONDO" />
              <XRef Type="MIM" ID="618336" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="80472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65971" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">POLE-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLE-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">POLE-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1735546" SubmissionDate="2019-02-26" DateLastUpdated="2019-02-25" DateCreated="2019-02-25">
        <ClinVarSubmissionID localKey="174762.0004_INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY" title="POLE, 1-BP DEL, 5265G_INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY" />
        <ClinVarAccession Accession="SCV000886485" DateUpdated="2019-02-25" DateCreated="2019-02-25" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (c.5265delG, NM_006231.3) in exon 39 of the POLE gene, causing a frameshift predicted to result in a premature termination codon (Ile1756SerfsTer5) that was found in compound heterozygous state in 2 Australian sisters (P11 and P12) with intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI; 618336) by Logan et al. (2018), see 174762.0003.</Attribute>
              <Citation>
                <ID Source="PubMed">30503519</ID>
              </Citation>
              <XRef DB="OMIM" ID="618336" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLE" />
          </GeneList>
          <Name>POLE, 1-BP DEL, 5265G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 5265G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="174762.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1251533" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="362221|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000653353" DateUpdated="2024-02-14" DateCreated="2017-12-26" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23230001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25948378</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30503519</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30503519</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile1756Serfs*5) in the POLE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLE are known to be pathogenic (PMID: 23230001, 25948378, 30503519). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive IMAGe syndrome (PMID: 30503519). ClinVar contains an entry for this variant (Variation ID: 473720). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.133218346del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8839700" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="38473354|POLE-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004759961" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The POLE c.5265delG variant is predicted to result in a frameshift and premature protein termination (p.Ile1756Serfs*5). This variant was reported along with a second POLE variant in two individuals with IMAGE-I syndrome (Table 1, Nakano et al. 2022. PubMed ID: 35534205). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. It is interpreted as pathogenic in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/473720/). Pathogenic variants in POLE leading to loss of POLE protein function have been reported in individuals with autosomal recessive intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGe-I) syndrome (Pachlopnik Schmid et al. 2012. PubMed ID: 23230001; Thiffault et al. 2015. PubMed ID: 25948378; Long et al. 2018. PubMed ID: 30503519; Nakano et al. 2022. PubMed ID: 35534205). This variant is interpreted as likely pathogenic for autosomal recessive IMAGe-I syndrome and as a variant of uncertain significance for autosomal dominant POLE-associated disorders.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006231.3:c.5265delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POLE-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1735546" TraitType="Disease" MappingType="Name" MappingValue="INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C5193036" Name="Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1251533" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8839700" TraitType="Disease" MappingType="Name" MappingValue="POLE-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="POLE-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

